Chronic kidney disease in long-term survivors of hematopoietic cell transplant

Bone Marrow Transplantation

Volumn 39, Issue 4, 2007, Pages 223-229

  Hingorani, S ^a,b   Guthrie, K A ^a,b   Schoch, G ^a,b   Weiss, N S ^a,b   McDonald, G B ^a,b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; BUSULFAN; COTRIMOXAZOLE; CREATININE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; FLUCONAZOLE; FLUDARABINE; GANCICLOVIR; MELPHALAN; METHOTREXATE; TACROLIMUS; THIOTEPA;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE KIDNEY FAILURE; ADOLESCENT; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CANDIDIASIS; CHILD; CHRONIC GRAFT VERSUS HOST DISEASE; CHRONIC KIDNEY DISEASE; CHRONIC MYELOID LEUKEMIA; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CYTOMEGALOVIRUS INFECTION; DEMOGRAPHY; DISEASE ASSOCIATION; FEMALE; GLOMERULUS FILTRATION RATE; HEMATOLOGIC MALIGNANCY; HERPES SIMPLEX; HUMAN; INFANT; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; STREPTOCOCCUS INFECTION; SURVIVAL; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; GLOMERULAR FILTRATION RATE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; KIDNEY FAILURE, ACUTE; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RENAL INSUFFICIENCY, CHRONIC; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVORS; WHOLE-BODY IRRADIATION;

EID: 33846994395     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1705573     Document Type: Article

References (43)

1. Cohen E, Lawton C, Moulder J. Bone marrow transplant nephropathy: radiation nephritis revisited. Nephron 1995; 70: 217-222.
2. Tarbell N, Guinan E, Neimeyer C, Mauch P, Sallan S, Weinstein H. Late onset of renal dysfunction in survivors of bone marrow transplantation. Int J Radiat Oncol Biol Phys 1988; 15: 99-104.
3. Cohen E, Piering W, Kabler-Babbitt C, Moulder J. End-stage renal disease (ESRD) after bone marrow transplantation: Poor survival compared to other causes of ESRD. Nephron 1998; 79: 408-412.
4. Lonnerholm G, Carlson K, Bratteby L, Backlund L, Hagberg H, Rikner G et al. Renal function after autologous bone marrow transplantation. Bone Marrow Transplant 1991; 8: 129-134.
5. Leblond V, Sutton L, Jacquiaud C, Item C, Sadoun R, Jaudon M et al. Evaluation of renal function in 60 long-term survivors of bone marrow transplantation. J Am Soc Nephrol 1995; 6: 1661-1665.
6. Kist-van Holthe J, van Zwet J, Brand R, van Weel M, Vossen J, van der Heijden A. Bone marrow transplantation in children: Consequences for renal function shortly after and 1 year post-BMT. Bone Marrow Transplant 1998; 22: 559-564.
7. Miralbell R, Bieri S, Mermillad B, Helg C, Sancho G, Pastoors B et al. Renal toxicity after allogeneic bone marrow transplantation: The combined effects of total-body irradiation and graft-versus-host disease. J Clin Oncol 1996; 14: 579-585.
8. Miralbell R, Sancho G, Bieri S, Carrio I, Helg C, Brunet S et al. Renal insufficiency in patients with hematologic malignancies undergoing total body irradiation and bone marrow transplantation: A prospective assessment. Int J Radiat Oncol Biol Phys 2004, 58: 809-816.
9. Frisk P, Bratteby L, Carlson K, Lonnerholm G. Renal function after autologous bone marrow transplantation in children: A long-term prospective study. Bone Marrow Transplant 2002; 29: 129-136.
10. Lawton C, Cohen E, Barber-Derus S, Murray K, Ash R, Casper J et al. Late renal dysfunction in adult survivors of bone marrow transplantation. Cancer 1991; 67: 2795-2800.
11. Manjunath G, Sarnak M, Levey A. Prediction equations to estimate glomerular filtration rate: An update. Curr Opin Nephrol Hypertens 2001; 10: 785-792.
12. Schwartz G, Brion L, Spitzer A. The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children and adolescents. Pediat Clin N Am 1987; 34: 571-590.
13. Buckner DC, Bensinger W. Preparative regimens. In: Thomas ED, Blume KG, Forman SJ (eds). Hematopoietic Cell Transplantation, 2nd edn. Blackwell Science: Malden, 1999, pp 123-134.
14. Carella A, Champlin R, Slavin S, McSweeney P, Storb R. Mini-allografts: ongoing trials in humans. Bone Marrow Transplant 2000; 25: 345-350.
15. Chao NJ, Holler E, Deeg H. Prophylaxis and treatment of acute graft-vs-host disease. In: Ferrara J, Cooke K, Deeg H (eds). Graft-vs-Host Disease, 3rd edn. Marcel Dekker: New York, 2005, pp 459-479.
16. Wingard JR. Bacterial infections. In: Thomas ED, Blume KG, Forman SJ (eds). Hematopoietic Cell Transplant, 3rd edn. Blackwell Science: Malden, 2004, pp 665-682.
17. Zaia JA. Cytomegalovirus infections. In: Thomas ED, Blume KG, Forman SJ (eds). Hematopoietic Cell Transplantation, 3rd edn. Blackwell Science: Malden, 2004, pp 701-726.
18. Ito J. Herpes simplex virus infections. In: Thomas ED, Blume KG, Forman SJ (eds). Hematopoietic Cell Transplantation, 3rd edn. Blackwell Science: Malden, 2004, pp 727-731.
19. Brown JM. Fungal infections after hematopoietic cell transplant. In: Thomas ED, Blume KG, Forman SJ (eds). Hematopoietic Cell Transplant, 3rd edn. Blackwell Science: Malden, 2004, pp 683-700.
20. Ferrara J. Pathogenesis of acute graft versus-host disease: Cytokines and cellular effectors. J Hematother Stem Cell Res 2000; 9: 299-306.
21. Vieira J, Noronha I, Matheiros D, Burdmann E. Cyclosporine induced interstitial fibrosis and arteriolar TGF-beta expression with preserved renal blood flow. Transplantation 1999; 68: 1746-1753.
22. El Seisi S, Gupta R, Clase C, Forrest D, Milandinovic M, Couban S. Renal pathology at autopsy in patients who died after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2003; 9: 683-688.
23. Couriel D, Caldera H, Champlin R, Komanduri K. Acute graft-versus-host disease: Pathophysiology, clinical manifestations, and management. Cancer 2004; 101: 1936-1946.
24. Krenger W, Hill G, Ferrara J. Cytokine cascades in acute graft-versus-host disease. Transplantation 1997; 64: 553-558.
25. Takatsuka H, Takemoto Y, Yamada S, Wada H, Tamura S, Fujimori Y et al. Complications after bone marrow transplantation are manifestations of systemic inflammatory response syndrome. Bone Marrow Transplant 2000; 26: 419-426.
26. Seconi J, Watt V, Ritchie D. Nephrotic syndrome following allogeneic stem cell transplantation associated with increased production of TNF-alpha and interferon-gamma by donor T-cells. Bone Marrow Transplant 2003; 32: 447-450.
27. Teshima T, Ordermann R, Reddy P, Gagin S, Liu C, Cooke K et al. Acute graft-versus-host disease does not require alloantigen expression on host epithelium. Nat Med 2002; 8: 575-581.
28. Kansu E. The pathophysiology of chronic graft-versus-host disease. Int J Hematol 2004; 79: 209-215.
29. Kitamura K, Suto T. TGF-beta and glomerulonephritis: Anti-inflammatory versus prosclerotic actions. Nephrol Dial Transplant 1997; 12: 669-679.
30. Negri A. Prevention of progressive fibrosis in chronic renal diseases: antifibrotic agents. J Nephrol 2004; 17: 496-503.
31. Langham R. Transforming growth factor beta1 and tumor growth factor beta-inducible gene-H3 in nonrenal transplant cyclosporine nephropathy. Transplantation 2001; 72: 1826-1829.
32. Disel U, Paydas S, Dogan A, Gulfiliz G, Yavuz S. Effect of colcincine on cyclosporine nephrotoxicity, reduction of TGF-beta overexpression, apoptosis, and oxidative damage: An experimental animal study. Transplant Proc 2004; 36: 1372-1376.
33. Antignac C, Gubler M-C, Leverger G, Broyer M, Habib R. Delayed renal failure with extensive mesangiolysis following bone marrow transplantation. Kidney Int 1989; 35: 1336-1344.
34. Rabinowe S, Soiffer R, Tarbell N, Neuberg D, Freedman A, Seifter J et al. Hemolytic-uremic syndrome following bone marrow transplantation in adults for hematologic malignancies. Blood 1991; 77: 1837-1844.
35. Myers B, Ross J, Newton L, Leutscher J, Perlroth M. Cyclosporine-associated chronic nephropathy. N Engl J Med 1984; 311: 699-705.
36. Hornung T, de Goede C, O'Brien C, Moghal N, Dark J, O'Sullivan J. Renal function after pediatric cardiac transplantation: The effect of early cyclosporin dosage. Pediatrics 2001; 107: 1346-1350.
37. Rubel J, Milford E, McKay D, Jarcho J. Renal insufficiency and end-stage renal disease in the heart transplant population. J Heart Lung Transplant 2004; 23: 289-300.
38. Ojo A, Held P, Port K, Wolfe R, Leichtman A, Young E et al. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 2003; 349: 931-940.
39. Juckett M, Cohen E, Keever-Taylor C, Zheng Y, Lawton C, Moulder J et al. Loss of renal function following bone marrow transplantation: An analysis of angiotensin converting enzyme D/I polymorphism and other clinical risk factors. Bone Marrow Transplant 2001; 27: 451-456.
40. Lawton C, Cohen E, Murray K, Derus S, Casper J, Drobyski, W et al. Long-term results of selective renal shielding in patients undergoing total body irradiation in preparation for bone marrow transplantation. Bone Marrow Transplant 1997; 20: 1069-1074.
41. Van Why S, Friedman A, Wei L, Hong R. Renal insufficiency after bone marrow transplantation in children. Bone Marrow Transplant 1991; 7: 383-388.
42. Kist-van Holthe J, Goedvolk C, Brand R, van Weel M, Bredius R, van Oostayen J et al. Prospective study of renal insufficiency after bone marrow transplantation. Pedatric Nephrol 2002; 17: 1032-1037.
43. Weiss AS, Sandamaier BM, Storer B, Storb R, McSweeney P, Parikh CR. Chronic kidney disease following non-myeloablative hematopoietic cell transplantation. Am J Transplant 2006; 6: 89-94.